A High Content Clonogenic Survival Drug Screen Identifies MEK Inhibitors as Potent Radiation Sensitizers for KRAS Mutant Non–Small-Cell Lung Cancer

201445 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: Journal of Thoracic Oncology

Volume 9, Issue 7, pp. 965-973

Field-Weighted Citation Impact: 1.64